VivoSim Labs Breaks Into China, Launches NAMkind Toxicology Sales
VivoSim Labs secures its first NAMkind sales in China, boosting global predictive toxicology adoption and aligning with new non‑animal testing regulations.
3 minutes to read
VIVOSIM LABS INC
VivoSim Expands NAMKind Toxicology Platform to Asia‑Pacific, Boosting Investor Interest
VivoSim Labs expands its NAMKind toxicology platform into Asia‑Pacific via JCBio and Tekon Biotech, delivering 30‑day human‑based liver & GI safety insights for faster drug development.
3 minutes to read